Gastric Volume and Colorectal Surgery (EVOL)

July 27, 2022 updated by: University Hospital, Angers

Ultrasonographic Evaluation of the Evolution of the Gastric Volume After Colorectal

Postoperative ileus (POI) is a serious complication after colorectal surgery. One of its most frequent consequences is the replacement of nasogastric tube because of the vomiting. Vomiting is due to the distension of the stomach and information on the evolution of gastric filling after surgery could help to better understand the physiopathology of POI. It could also give indication to help the physician in the management of POI.

The ultrasonography has been shown to be a reliable technic to assess the gastric emptying.

To date, there is no indication in the literature about the evolution of the gastric filling after colorectal surgery while these information could help to identify patients at risk for POI and to predict the need for POI replacement.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • Recruiting
        • CHU Angers
        • Contact:
          • Aurélien Venara

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient undergoing colorectal resection whatever the surgical access

Exclusion Criteria:

  • contra-indication to ultrasonography performance
  • history of gastrectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gastric antrum measurement
Ultrasonography of the stomach is performed to measure the diameter of the antrum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Diameter of the gastric antrum
Time Frame: immediately before the procedure and each postoperative day up to discharge (mean 7 days)
immediately before the procedure and each postoperative day up to discharge (mean 7 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative ileus
Time Frame: in the morning up to 30 postoperative days
in the morning up to 30 postoperative days
Postoperative quality of life: GIQLI
Time Frame: before discharge
GIQLI
before discharge
postoperative morbidity
Time Frame: within 30 postoperative days
Dindo Clavien Scale (from 1 (minor) to 5 (death))
within 30 postoperative days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aurélien VENARA, MD, PhD, University Hospital, Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2020

Primary Completion (Anticipated)

August 1, 2022

Study Completion (Anticipated)

September 1, 2022

Study Registration Dates

First Submitted

June 24, 2020

First Submitted That Met QC Criteria

July 3, 2020

First Posted (Actual)

July 8, 2020

Study Record Updates

Last Update Posted (Actual)

July 28, 2022

Last Update Submitted That Met QC Criteria

July 27, 2022

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 19.12.02.56807

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Ileus

Clinical Trials on ultrasonography

3
Subscribe